Dynamics and relationsip of COVID-19 infection after SARS-COV-2 vaccination plan rollout in Colombia
Dinámica y relación del contagio del COVID-19 después de iniciado el plan de vacunación contra el SARS-COV-2 en Colombia
Main Article Content
Abstract
Introduction: since the first cases of coronavirus disease 2019 (COVID-19) caused by acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were identified in December 2019, the resulting pandemic has account for more than 130 million confirmed cases and more than 2.8 million deaths worldwide, as of April 6 2021. Objective: to show if there is a correlation between COVID-19 infections and SARS-COV-2 vaccination from February 17 to May 17 2021. Methodology: the information was obtained from the Ministry of Health and Social Protection website, based on COVID 19 infection and SARS-COV-2 vaccination daily reports for said period. Results: the p-value for the tests for COVID-19 infection and vaccination variables is 0.000, which is less than α =0.01, thus, the hypothesis (Ha) is accepted, which means that the Pearson correlation test indicates that there is a relationship between the number of COVID-19 infections and vaccination against SARS-COV-2 in Colombia. Conclusion: since vaccination against COVID-19 was started in mid-February 2021 in Colombia, there has been no evidence of a decrease in the number of COVID-19 infections. This study provides the first data in the country on how the SARS-COV-2 vaccine impacts the population.
Keywords:
Downloads
Article Details
References
Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL. Spread of SARS-CoV-2 in the Icelandic Population. N Engl J Med. 2020;382(24):2302-2315. doi: 10.1056/NEJMoa2006100. DOI: https://doi.org/10.1056/NEJMoa2006100
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5 DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
World Helath Organization. WHO Coronavirus (COVID-19) Dashboard [Internet]. World Helath Organization; 2021 [consultado 6 de abril 2021]; Disponible en: https://covid19.who.int/.
Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586(7830):516-527. doi: 10.1038/s41586-020-2798-3 DOI: https://doi.org/10.1038/s41586-020-2798-3
Walsh EE, Frenck Jr RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. N Engl J Med. 2020;383(25):2439-2450. doi: 10.1056/NEJMoa202790 DOI: https://doi.org/10.1056/NEJMoa2027906
Wang J, Peng Y, Xu H, Cui Z, Williams RO. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech. 2020;21(6):225. doi: 10.1208/s12249-020-01744-7 DOI: https://doi.org/10.1208/s12249-020-01744-7
Rawat K, Kumari P, Saha, L. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. Eur J Pharmacol. 2021;892:173751. doi: 10.1016/j.ejphar.2020.173751 DOI: https://doi.org/10.1016/j.ejphar.2020.173751
Abbasi K. Behavioural fatigue: a flawed idea central to a flawed pandemic response. BMJ. 2020;370:m3093. doi: 10.1136/bmj.m3093 DOI: https://doi.org/10.1136/bmj.m3093
Rypdal K, Bianchi FM, Rypdal, M. Intervention Fatigue is the Primary Cause of Strong Secondary Waves in the COVID-19 Pandemic. Int J Environ Res Public Health. 2020;17(24):9592. doi: 10.3390/ijerph17249592 DOI: https://doi.org/10.3390/ijerph17249592
Priesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T, et al. Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections. Lancet. 2021;397(10269):92-93. doi: 10.1016/S0140-6736(20)32625-8
Priesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T, et al. Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections. Lancet. 2021;397(10269):92-93. doi: 10.1016/S0140-6736(20)32625-8 DOI: https://doi.org/10.1016/S0140-6736(20)32625-8
Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):eabg3055. doi: 10.1126/science.abg3055 DOI: https://doi.org/10.1126/science.abg3055
Abbott S, Funk S, CMMID COVID-19 Working Group. Local area reproduction numbers and S-gene target failure [Internet]. Centre for Mathematical Modelling of Infectious Diseases 2021. [Citado 10 de junio de 2021]; Disponible en: https://cmmid.github.io/topics/covid19/local-r-sgtf.html
Horby P, Huntley C, Davies N, Edmunds J, Ferguson N, Medley G, Semple C. NERVTAG paper on COVID-19 variant of concern B.1.1.7. Department of Health and Social Care. [Citado 10 de junio de 2021]; Disponible en: https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-variant-of-concern-b117
Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science. 2021;371(6532):916–921. doi: 10.1126/science.abe6959 DOI: https://doi.org/10.1126/science.abe6959
Ramos AM, Vela-Pérez M, Ferrández MR, Kubik AB, Ivorra B. Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19. Preprint in ResearchGate. [Citado 10 de junio de 2021]; Disponible en: https://doi.org/10.13140/RG.2.2.32580.24967/2
Suárez-Ibujes M. Coeficiente de correlación de Karl Pearson [Internet]. 2021. [citado 14 mayo 2021]; Disponible en: https://www.monografias.com/trabajos85/coeficiente-correlacion-karl-pearson/coeficiente-correlacion-karl-pearson.shtml
Díaz-Pinzón JE. Estudio de los resultados del contagio por COVID-19 a nivel mundial. Repert Med Cir. 2020;29 (Núm. Supl.1):65-71. doi: 10.31260/RepertMedCir.01217372.1089 DOI: https://doi.org/10.31260/RepertMedCir.01217372.1089
Díaz-Pinzón, J.E. Proyección del COVID-19 en Colombia. Rev. Med. [Internet]. 11 de septiembre de 2020 [citado 19 de abril de 2021]; 28(1). DOI: https://doi.org/10.18359/rmed.4702 DOI: https://doi.org/10.18359/rmed.4702
Díaz-Pinzón, J.E. Soporte técnico de simulación Phet en la enseñanza y aprendizaje de fracciones equivalentes. RIUQ. 2016;28(2):31-41. doi: https://doi.org/10.33975/riuq.vol28n2.6 DOI: https://doi.org/10.33975/riuq.vol28n2.6